GILEAD SCIENCES INC. REGISTERED SHARES DL -,001
Technische Signale
| Signale Details | |
|---|---|
| WKN / ISIN | - / US3755581036 |
| Börse | Frankfurt |
| Schluss | 75,00 |
| Konservatives Signal |  19.09.24 |
| MACD |  29.08.24 |
| Momentum | 01.07.24 |
| Bollinger Bands | 12.02.24 |
| TBI | 03.09.24 |
| Schnitt GD 90 | 11.07.24 |
Analystenbewertung
| Bewertungstrend | aktuell | Vorwoche | Vormonat |
|---|---|---|---|
| Bewertung | 2,28 | 2,28 | 2,30 |
| Anzahl der Analysten | 29 | 29 | 30 |
| Kaufen | 8 | 8 | 8 |
| Übergewichten | 7 | 7 | 7 |
| Halten | 13 | 13 | 14 |
| Untergewichten | 0 | 0 | 0 |
| Verkaufen | 1 | 1 | 1 |
| Aktueller Durchschnitt von insgesamt 29 Analysten: 2,28 | |||
| Planzahlen (in EUR) | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Umsatz | 27,12 Mrd. | 27,59 Mrd. | 27,98 Mrd. |
| EBIT | 7,07 Mio. | 7,26 Mrd. | 11,67 Mrd. |
| EBITDA | 9,51 Mio. | 10,08 Mrd. | 13,87 Mrd. |
| Nettoverschuldung** | 15,62 Mrd. | 18,17 Mrd. | 13,18 Mrd. |
Umsatz |
EBIT |
EBITDA |
Nettoverschuldung** |
| Dividende | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Dividende / Aktie | 2,72 EUR | 3,07 USD | 3,23 USD |
| Dividendenrendite | 3,74% | 3,66% | 3,85% |
Dividende / Aktie (in USD) |
Dividendenrendite (in %) |
||
| Analystenhäuser |
|---|
| Argus Research Company,Atlantic Equities LLP,Baird,Baptista Research,Barclays,Berenberg,BMO Capital Markets Equity Research,BMO Capital Markets U.S. (Historical),BofA Global Research,Brean Capital,BTIG,BWS Financial Inc.,Cantor Fitzgerald & Co.,CFRA Equity Research,CFRA Research,Citigroup Inc,Credit Suisse,Crisp Idea,Daiwa Capital Markets America Inc.,Daiwa Securities Co. Ltd.,Deutsche Bank,Equisights,Erste Group Bank AG,Evercore ISI,FBR Capital Markets & Co.,First Global Stockbroking (P) Ltd.,G. Research, LLC,Goldman Sachs,Guggenheim Securities, LLC,HSBC,J.P. Morgan,Jefferies LLC,JMP Securities,Ladenburg Thalmann & Company,Lazard Capital Markets,Leerink Partners LLC,Maxim Group,Merriman Capital, Inc,Mizuho Securities USA LLC,Morgan Joseph TriArtisan LLC,Morgan Stanley,Morningstar Inc.,Needham & Company,Nomura Securities Co. Ltd.,Oppenheimer & Co. Inc.,Piper Sandler Companies,Raymond James & Associates,RBC Capital Markets,Redburn Atlantic,Roth MKM,Sanford C. Bernstein & Co., LLC,Shinhan Investment Corp.,Siebert Williams Shank & Co., LLC,Stifel, Equities Research,TD Cowen,ThinkEquity LLC,Tianfeng Securities Brokerage Co., Ltd,Truist Securities,UBS Investment Bank,Wedbush Securities Inc.,Wells Fargo Securities, LLC,William Blair & Company L.L.C.,Wolfe Research, LLC.,Zephirin Group, Inc. |
| Hinweis |
|---|
|
Selected Data supplied by Standard & Poors
* Unabhängige Schätzung (Gewinnwachstum (in %)) ** Nettobargeldbestand bei negativen Schätzungen |